HROW FY 2020 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$49M-4.5% YoY

Gross Profit

$34M70.4% margin

Operating Income

$385,0000.8% margin

Net Income

-$3M-6.9% margin

EPS (Diluted)

$-0.13

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$57M

Total Liabilities

$31M

Stockholders' Equity

$27M

Cash & Equivalents

$4M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$51M	-4.5%
Gross Profit	$34M	$34M	-0.0%
Operating Income	$385,000	-$5M	+108.0%
Net Income	-$3M	$168,000	-2098.2%